HIV expenditure on prevention and treatment in Georgia

Georgia: HIV expenditure on prevention and treatment was 17.38 million constant 2019 US$ in 2024. β–² Rising

Latest (2024)
17.38 million constant 2019 US$
Change on year
down 8.6%
World rank
53rd
of 144 countries
All-time high
19.93 million constant 2019 US$
in 2017
All-time low
0 constant 2019 US$
in 2018
Years of data
16
2006–2024

HIV expenditure on prevention and treatment in Georgia, 2006–2024

05.0M10.0M15.0M20.0M2006201520242006: 5.3M constant 2019 US$2008: 8.2M constant 2019 US$2009: 10.4M constant 2019 US$2011: 14.3M constant 2019 US$2012: 16.6M constant 2019 US$2013: 16.1M constant 2019 US$2014: 17.0M constant 2019 US$2015: 16.0M constant 2019 US$2017: 19.9M constant 2019 US$2018: 0 constant 2019 US$2019: 15.9M constant 2019 US$2020: 15.9M constant 2019 US$2021: 16.5M constant 2019 US$2022: 17.5M constant 2019 US$2023: 19.0M constant 2019 US$2024: 17.4M constant 2019 US$

Source: Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data. Measured in constant 2019 US$.

Analysis

The most recent figure for hiv expenditure on prevention and treatment in Georgia is 17.38 million constant 2019 US$, measured in 2024.

That represents a change of down 8.6% on the previous year and up 2.4% over ten years.

Over the whole period, hiv expenditure on prevention and treatment in Georgia peaked at 19.93 million constant 2019 US$ in 2017 and was at its lowest, 0 constant 2019 US$, in 2018.

Georgia ranks 53rd of 144 countries on this measure, in the middle of the range.

The long-run direction has been consistently rising across the 16 years of available data.

Averages by decade

DecadeAverage LowestHighest Years
2000s 7.96 million constant 2019 US$ 5.29 million constant 2019 US$ 10.37 million constant 2019 US$ 3
2010s 14.46 million constant 2019 US$ 0 constant 2019 US$ 19.93 million constant 2019 US$ 8
2020s 17.26 million constant 2019 US$ 15.92 million constant 2019 US$ 19.01 million constant 2019 US$ 5

Countries ranked near Georgia

  1. 50 Pakistan 20.51 million constant 2019 US$ compare
  2. 51 Bulgaria 20.13 million constant 2019 US$ compare
  3. 52 Burundi 18.41 million constant 2019 US$ compare
  4. 54 Burkina Faso 16.61 million constant 2019 US$ compare
  5. 55 Venezuela 16.21 million constant 2019 US$ compare
  6. 56 Tajikistan 15.37 million constant 2019 US$ compare

See the full ranking of 144 places β†’

More health data for Georgia

All data for Georgia β†’

Frequently asked questions

What is hiv expenditure on prevention and treatment in Georgia?
Hiv expenditure on prevention and treatment in Georgia was 17.38 million constant 2019 US$ in 2024, according to Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data.
What is the highest hiv expenditure on prevention and treatment recorded in Georgia?
The highest recorded value was 19.93 million constant 2019 US$ in 2017.
What is the lowest hiv expenditure on prevention and treatment recorded in Georgia?
The lowest recorded value was 0 constant 2019 US$ in 2018.
How does Georgia rank for hiv expenditure on prevention and treatment?
Georgia ranks 53rd out of 144 countries with data for 2024.
Is hiv expenditure on prevention and treatment rising or falling in Georgia?
Over the last ten years it is up 2.4%. The long-run trend across the full record is rising.
Where does this Georgia data come from?
The figures come from Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as part of HIV expenditure on prevention and treatment. Statizoid updates them automatically from the source API.

Download this data

CSV Β· JSON β€” 16 observations, free to reuse under CC BY 4.0 (Our World in Data).

About this data

Indicator
HIV expenditure on prevention and treatment
Unit
constant 2019 US$
Source
Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
144 places, 1,552 data points, 2002–2024
Last refreshed

Total in-country spending on HIV programs and services.